Intrasplenic Inoculation

A Method for Rescuing Hybridoma Clones
  • Rosalie Ber
  • Pamela L. Witte
Part of the Contemporary Biomedicine book series (CB, volume 7)

Abstract

Although only a decade has passed since Kohler and Milstein (1) described the first production of hybridomas, monoclonal antibodies (Mab) have become a ubiquitous tool in the hands of scientists from a wide array of interests and specialties. A number of commercially produced Mabs are available for a variety of purposes, but most researchers require “tailor-made” Mabs. Not all of these researchers have suitable facilities and/or experience in tissue culture; and, even in the hands of experts, precious Mab-producing hybridoma clones are often lost as a result of the perils and hazards of cell culture. The archenemies of all cell culture laboratories are mycoplasma, bacteria, yeast, and fungus contaminations. In the absence of suitable sterile facilities (e.g., laminar flow hood) and in the hands of the novice, these perils are prominent. In addition, at times (for reasons poorly understood), the newly fused cells undergo a few rounds of replication, but fail to multiply when attempts are made to expand the culture. Furthermore, despite careful cryopreserving protocols, there are often problems with reestablishing hybridoma cells in culture from frozen stocks.

Keywords

Hydrate Cage Titration Syringe Pyruvate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kohler G. and Milstein C.: 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497.PubMedCrossRefGoogle Scholar
  2. 2.
    Cancro M. and Potter M: 1976. The requirement of an adherent cell substratum for the growth of developing plasmacytoma cells in vivo. J. Exp. Med. 144: 1554–1567.PubMedCrossRefGoogle Scholar
  3. 3.
    Ber R. and Lanir N.: 19K4. Fusion of plasmacytoma and host cells in vivo: Selection of proliferating and nonproliferating cultures. J. Natl. Cancer Inst. 72: 403–409.Google Scholar
  4. 4.
    Witte P. L. and Ber R.: 1983. Improved efficiency of hybridoma ascites production by intrasplenic inoculation in mice. J. Natl. Cancer Inst. 70: 575–577.PubMedGoogle Scholar
  5. 5.
    Spitz M., Spitz L., Thorpe R., and Eugui E.: 1984. Intrasplenic primary immunization for the production of monoclonal antibodies. J. Immunol. Methods 70: 39–43PubMedCrossRefGoogle Scholar

Copyright information

© The Humana Press Inc. 1987

Authors and Affiliations

  • Rosalie Ber
  • Pamela L. Witte

There are no affiliations available

Personalised recommendations